Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC

Eitemau Tebyg

• Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs
  gan: Zhu, Yan-juan, et al.
  Cyhoeddwyd: (2017)
• Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
  gan: Liang, Hengrui, et al.
  Cyhoeddwyd: (2020)
• Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients
  gan: Su, Jian, et al.
  Cyhoeddwyd: (2017)
• Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays
  gan: Jiang, Xi-Wen, et al.
  Cyhoeddwyd: (2019)
• Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients
  gan: Yan, Han, et al.
  Cyhoeddwyd: (2015)